Robert H. Rosen

2014

In 2014, Robert H. Rosen earned a total compensation of $4.1M as President and Chief Commercial Officer at Heron Therapeutics, a 52% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$252,801
Option Awards$3,325,780
Salary$540,750
Total$4,119,331

Rosen received $3.3M in option awards, accounting for 81% of the total pay in 2014.

Rosen also received $252.8K in non-equity incentive plan and $540.8K in salary.

Rankings

In 2014, Robert H. Rosen's compensation ranked 2,047th out of 13,032 executives tracked by ExecPay. In other words, Rosen earned more than 84.3% of executives.

ClassificationRankingPercentile
All
2,047
out of 13,032
84th
Division
Manufacturing
719
out of 4,966
86th
Major group
Chemicals And Allied Products
225
out of 1,686
87th
Industry group
Drugs
172
out of 1,365
87th
Industry
Pharmaceutical Preparations
143
out of 1,043
86th
Source: SEC filing on April 29, 2016.

Rosen's colleagues

We found three more compensation records of executives who worked with Robert H. Rosen at Heron Therapeutics in 2014.

2014

Barry Quart

Heron Therapeutics

Chief Executive Officer

2014

Paul Marshall

Heron Therapeutics

Senior Vice President, Technical Operations

2014

Brian Drazba

Heron Therapeutics

Chief Financial Officer

News

In-depth

You may also like